VITROS Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection of immunoglobulin G antibody to hepatitis C virus (anti-HCV) in human serum and plasma. REF 680 2454, IVD -- Ortho-Clinical Diagnostics High Wycombe UK. Note that one sales unit has 5 Reagent Packs contained within it. Each Reagent Pack can test for 100 samples (patient, Quality Control, etc.).
Published October 1, 2014 · Recall initiated: August 6, 2014
Summary
FDA records medical device Class II recall Z-2671-2014, published October 1, 2014 and initiated August 6, 2014. Recalling firm: ORTHO-CLINICAL DIAGNOSTICS; Status: Terminated; Reported quantity: 463 sales units; Lot: Lot 9090 (exp. December 15, 2014). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
VITROS Immunodiagnostic Products Anti-HCV kit lot 9090 has been observed producing sporadic lower than expected VITROS Anti-HCV test results due to an approximate signal loss of up to 66.2% which can result in unexpected negative test results being obtained for reactive sample fluids (quality control and patient samples).
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- ORTHO-CLINICAL DIAGNOSTICS
- Distributor
- NY, NJ, CT, MA, PA, VA, MD, FL and GA
- Lot
- Lot 9090 (exp. December 15, 2014)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United Kingdom
Related recalls
- FDAVITROS Immunodiagnostic Products NT-pro BNP Reagent Pack, REF/Catalog 680 2156, IVD --- Ortho-ClinicalApril 19, 2017
- FDAVITROS Immunodiagnostic Products TSH Reagent Pack, REF/Catalog Number/Product Code 191 2997, Unique DeviceAugust 24, 2016
- FDA0.9% Sodium Chloride Injection, USP BD PosiFlush(TM) SF Saline Flush Syringe 10 mL REF#306553 used inOctober 1, 2014
- FDAEZ-IO 45mm (40kg & up) Needle Set, part number 9079-VC-005; lot code 3606455October 1, 2014
- FDA98" (249 cm) Appx 12.3 ml, 60 Drop Primary Set w/Pre-Slit Port, STAT 2 Flow Controller, Rotating Luer, ItemOctober 1, 2014
- FDAVITROS® Immunodiagnostic Products CA 19-9 Calibrators and Reagent Packs, Lot 1320 VITROS® CA 19-9 ReagentAugust 20, 2014
Questions about this recall
Was VITROS Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection of immunoglobulin G antibody to hepatitis C virus (anti-HCV) in human serum and plasma. REF 680 2454, IVD -- Ortho-Clinical Diagnostics High Wycombe UK. Note that one sales unit has 5 Reagent Packs contained within it. Each Reagent Pack can test for 100 samples (patient, Quality Control, etc.). recalled?
Yes. FDA published recall Z-2671-2014 on October 1, 2014. Reported hazard: VITROS Immunodiagnostic Products Anti-HCV kit lot 9090 has been observed producing sporadic lower than expected VITROS Anti-HCV test results due to an approximate signal loss of up to 66.2% which can result in unexpected negative test results being obtained for reactive sample fluids (quality control and patient samples).
What should I do if I have this product?
Voluntary: Firm initiated · Letter